| Style | Citing Format |
|---|---|
| MLA | Bahreini SA, et al.. "The Association Between Anti-Ebna-1 Igg and Multiple Sclerosis Clinical Disease Activity." European Journal of Neurology, vol. 17, no. 10, 2010, pp. e95-. |
| APA | Bahreini SA, Zahednasab H, Saadatnia M, Jabalameli MR (2010). The Association Between Anti-Ebna-1 Igg and Multiple Sclerosis Clinical Disease Activity. European Journal of Neurology, 17(10), e95-. |
| Chicago | Bahreini SA, Zahednasab H, Saadatnia M, Jabalameli MR. "The Association Between Anti-Ebna-1 Igg and Multiple Sclerosis Clinical Disease Activity." European Journal of Neurology 17, no. 10 (2010): e95-. |
| Harvard | Bahreini SA et al. (2010) 'The Association Between Anti-Ebna-1 Igg and Multiple Sclerosis Clinical Disease Activity', European Journal of Neurology, 17(10), pp. e95-. |
| Vancouver | Bahreini SA, Zahednasab H, Saadatnia M, Jabalameli MR. The Association Between Anti-Ebna-1 Igg and Multiple Sclerosis Clinical Disease Activity. European Journal of Neurology. 2010;17(10):e95-. |
| BibTex | @article{ author = {Bahreini SA and Zahednasab H and Saadatnia M and Jabalameli MR}, title = {The Association Between Anti-Ebna-1 Igg and Multiple Sclerosis Clinical Disease Activity}, journal = {European Journal of Neurology}, volume = {17}, number = {10}, pages = {e95-}, year = {2010} } |
| RIS | TY - JOUR AU - Bahreini SA AU - Zahednasab H AU - Saadatnia M AU - Jabalameli MR TI - The Association Between Anti-Ebna-1 Igg and Multiple Sclerosis Clinical Disease Activity JO - European Journal of Neurology VL - 17 IS - 10 SP - e95 EP - PY - 2010 ER - |